Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 6:41 PM
Ignite Modification Date:
2025-12-24 @ 6:41 PM
NCT ID:
NCT00000857
Eligibility Criteria:
Inclusion Criteria
You may be eligible for this study if you:
* Are HIV-positive.
* Are 18-60 years old.
* Have a CD4 count less than 50 cells/mm3 or between 300-500 cells/mm3 within 30 days of study entry.
* Are expected to live at least 12 weeks.
* Agree to practice abstinence or use effective methods of birth control during the study.
Exclusion Criteria
You will not be eligible for this study if you:
* Have a history of cytomegalovirus (CMV) end-organ disease.
* Have a history of invasive fungal disease, unless the condition has been stable for 2 months.
* Have a history of severe allergic reactions to IL-2 or IL-12.
* Have a history of heart problems, autoimmune or rheumatologic disease, gastrointestinal bleeding, or any condition that would keep you from completing the study.
* Have MAC-related symptoms (fever, weight loss, frequent diarrhea) for at least 2 months prior to study entry.
* Are enrolled in another experimental research treatment study.
* Abuse alcohol or drugs.
* Are pregnant or breast-feeding.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
60 Years
Study:
NCT00000857
Study Brief:
Protocol Section:
NCT00000857